Daniel E. Geffken

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Concord, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Dunn, Esq., Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel E. Geffken

Form 4 holding Interim CFO

CalciMedica, Inc.

Security class
Warrant
Shares / value
10,000
Estimated value
Report date
17 May 2024
Price
Ownership
By SG Dan Equity Holdings, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

WINDTREE THERAPEUTICS INC /DE/

Security class
Stock Option (Right to Buy)
Shares / value
3,050
Estimated value
Report date
23 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

ProMIS Neurosciences Inc.

Security class
Option (right to buy)
Shares / value
2,500
Estimated value
Report date
26 Oct 2023
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Daniel E. Geffken

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .